Shockwave Medical (SWAV) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US82489T1043
ShockWave Medical, Inc. is a medical technology company that specializes in intravascular lithotripsy (IVL) technology to address calcified plaque in patients with peripheral and coronary vascular, as well as heart valve diseases in various countries. They provide innovative solutions for treating peripheral artery disease (PAD) with a range of IVL catheters, including the M5 and M5+ for medium-sized vessels, the S4 for small vessels, and the L6 for large vessels.
In addition to PAD, ShockWave Medical offers products for coronary artery disease treatment, such as the C2 and C2+ IVL catheters. Their products cater to interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors.
Established in 2009, ShockWave Medical is based in Santa Clara, California, and continues to revolutionize the medical device industry with its advanced IVL technology. To learn more about their groundbreaking solutions, visit their website at https://shockwavemedical.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
SWAV Stock Overview
| Market Cap in USD | 12,273m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 2019-03-07 |
SWAV Stock Ratings
| Growth 5y | 7.28 |
| Fundamental | 5.73 |
| Dividend | - |
| Rel. Performance vs Sector | 1.69 |
| Analysts | 3.00/5 |
| Fair Price Momentum | 381.78 USD |
| Fair Price DCF | 97.91 USD |
SWAV Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
SWAV Growth Ratios
| Growth 12m | 26.02% |
| Growth Correlation 12m | -14% |
| Growth Correlation 3m | 84% |
| CAGR 5y | 59.37% |
| Sharpe Ratio 12m | 0.45 |
| Alpha vs SP500 12m | -9.23 |
| Beta vs SP500 5y weekly | 1.68 |
| ValueRay RSI | 73.57 |
| Volatility GJR Garch 1y | 40.14% |
| Price / SMA 50 | 16.26% |
| Price / SMA 200 | 42.22% |
| Current Volume | 1155.6k |
| Average Volume 20d | 2136.7k |
External Links for SWAV Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 20, 2024, the stock is trading at USD 327.52 with a total of 1,155,587 shares traded.
Over the past week, the price has changed by -0.20%, over one month by +18.19%, over three months by +48.19% and over the past year by +23.38%.
According to ValueRays Forecast Model, SWAV Shockwave Medical will be worth about 431.4 in April 2025. The stock is currently trading at 327.52. This means that the stock has a potential upside of +31.72%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 316.1 | -3.47% |
| Analysts Target Price | 270.8 | -17.3% |
| ValueRay Target Price | 431.4 | 31.7% |